American Vanguard (AVD) to Release Earnings on Wednesday

American Vanguard (NYSE:AVD) is anticipated to announce its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $163.00 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Monday, March 16, 2026 at 10:30 AM ET.

American Vanguard Stock Performance

Shares of AVD stock opened at $4.49 on Monday. The company has a current ratio of 1.77, a quick ratio of 0.90 and a debt-to-equity ratio of 0.82. American Vanguard has a 12-month low of $3.28 and a 12-month high of $5.92. The business’s 50 day moving average is $4.63 and its two-hundred day moving average is $4.84. The company has a market capitalization of $127.83 million, a P/E ratio of -1.13 and a beta of 1.23.

Hedge Funds Weigh In On American Vanguard

A number of hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new stake in American Vanguard in the fourth quarter valued at approximately $52,000. Empowered Funds LLC boosted its position in shares of American Vanguard by 86.4% during the fourth quarter. Empowered Funds LLC now owns 42,690 shares of the basic materials company’s stock worth $163,000 after buying an additional 19,784 shares during the period. nVerses Capital LLC acquired a new stake in shares of American Vanguard in the fourth quarter valued at $42,000. Wellington Management Group LLP grew its stake in shares of American Vanguard by 4.4% in the fourth quarter. Wellington Management Group LLP now owns 1,700,161 shares of the basic materials company’s stock valued at $6,495,000 after buying an additional 71,632 shares in the last quarter. Finally, Oxford Asset Management LLP purchased a new stake in shares of American Vanguard in the 4th quarter valued at $117,000. Hedge funds and other institutional investors own 79.00% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Wall Street Zen cut American Vanguard from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.00.

American Vanguard Company Profile

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.